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Abstract: A series of 1,4-dihydropyridine derivatives (1a–g)  were prepared 
from Hantzsch syntheses. The compounds 1a–g were reacted with thiosemi-
carbazide to give the new series of compounds 2a–g. IR, 1H-NMR, 13C-NMR, 
mass spectral and elemental analysis confirmed the synthesized compounds. 
The synthesized compounds were also screened for their antimicrobial activity. 
Keywords: 1,4-dihydropyridine; thiosemicarbazide; condensation; antimicro-
bial activity. 
INTRODUCTION 
1,4-Dihydropyridine derivatives are of interest because of their biological 
activity, such as vasodilators, antihypertensive,1–4 anti-inflammatory,5 antihy-
poxic and anti-ischemic agents6 and calcium channel modulators of the nifedi-
pine type.7 Recently, it was reported that the amide group was involved in the 
3,5-position of 1,4-dihydropyridine derivatives and it exhibited pharmacological 
effects.8,9 Basically thiosemicarbazone containing heterocyclics have significant 
biological activity, such as antitumour, fungicidal, bactericidal, anti-
inflammatory and antiviral activities.10–13 In view of these observations, it was 
decided to synthesize a new series of 1,4-dihydropyridine derivatives (2a–g) and 
screen them for their level of antimicrobial activity. 
RESULTS AND DISCUSSION 
Chemistry 
The series of diethyl 2,6-dimethyl-4-substituted phenyl-1,4-dihydropyridine- 
-3,5-dicarboxylate (1a–f) are already published in literature14–19, but not their 
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antimicrobial screening. On the other hand the syntheses and antimicrobial scre-
ening of compound 1g has not been published. The compounds 1a–g were re-
acted with thiosemicarbazide to give 4-aryl-2,6-dimethyl-1,4-dihydropyridine- 
-3,5-dicarboxylic acid, 3,5-bis[2-(aminothioxomethyl)hydrazide] (2a–g)  by the 
hydrazinolysis method20,21 (Scheme 1). 
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1a, 2a : R = 2-Furyl
1b, 2b : R = -Ph
1c, 2c : R = 4-Cl-C6H4
1d, 2d : R = 4-OH-C6H4
1e, 2e : R = 4-NO2-C6H4
1f, 2f : R = 4-CH3O-C6H4
1g, 2g : R = 4-(CH3)2N-C6H4  
Scheme 1. Synthesis of the compounds 2a–g. 
Analytic and spectral data 
 
Diethyl 4-(furan-2-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
(1a). Yield: 75 %; m.p.158 °C; Anal. Calcd. for C17H21NO5: C, 63.94; H, 6.63; 
N, 4.39 %. Found: C, 63.98; H, 6.67; N, 4.35 %. IR (KBr, cm–1): 3349 (N–H str), 
3030 (Ar–H), 2940 (C–H str of CH3), 1745 (C=O, ester), 812 (Ar–H). 
1H-NMR 
(300 MHz, DMSO-d6, δ / ppm ): 8.20 (1H, s, NH of pyridine ring), 7.27 (1H, s, 
furyl ring), 6.10–6.27 (2H, d, furyl ring), 4.72 (1H, s, C4–H), 4.20 (4H, q, C3– 
–CH2CH3 and C5–OCH2CH3), 2.31 (6H, s, C2–CH3 and C6–CH3), 1.34 (6H, t, 
C2–OCH2CH3 and C6–OCH2CH3). 13C-NMR (300 MHz, DMSO-d6, δ / ppm ): 
142.1, 110.6, 106.7, 152.5 (furyl ring), 151.8 (C2,6), 33.2 (C4), 102.3 (3,5- 
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-COOCH2CH3), 61.1(3,5-COOCH2CH3), 14.9 (3,5-COOCH2CH3), 18.1 (2,6- 
-CH3). MS (m/z (relative abundance, %)): 320.15 (M++1, 40.2), 275.29, 231.24, 
203.23, 173.22, 161.20, 147.2, 134.12, 82.10. 
Diethyl 2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate (1b). 
Yield: 66 %; m.p. 253 °C; Anal. Calcd. for C19H23NO4: C, 69.28; H, 7.04; N, 
4.25 %. Found: C, 69.24; H, 7.07; N, 4.28 %. IR (KBr, cm–1): 3350 (N–H str), 
3034 (Ar–H), 2953 (C–H str of CH3), 1755 (C=O, ester), 802 (Ar–H). 1H-NMR 
(300 MHz, DMSO-d6, δ / ppm ): 8.25 (1H, s, NH of pyridine ring), 7.33–7.27 
(5H,  m, Ph-ring), 4.70 (2H, s,  C4–H), 4.22 (4H, q, C3–OCH2CH3 and C5– 
–OCH2CH3), 2.28 (6H, s, C2–CH3 and C6-CH3), 1.32 (6H, t, C2–OCH2CH3 
and C6–OCH2CH3). 13C-NMR (300 MHz, DMSO-d6, δ / ppm ): 125.1, 128.4, 
127.1, 144.8 (phenyl ring), 150.7 (C2,6), 101.9 (3,5-COOCH2CH3), 62.1 (3,5- 
-COOCH2CH3 ), 44.1 (C4), 19.1 (2,6-CH3 ), 15.4 (3,5-COOCH2CH3 ). MS (m/z 
(relative abundance, %)): 330.39 (M++1, 38.9), 285.33, 241.28, 185.26, 171.23, 
157.21, 81.11, 68.11. 
Diethyl 4-(4-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbo-
xylate (1c). Yield: 57 %; m.p. 240 °C. Anal. Calcd. for C19H22ClNO4: C, 62.72; 
H, 6.09; N, 3.85 %. Found: C, 62.75; H, 6.07; N, 3.81 %. IR (KBr, cm–1): 3332 
(N–H str), 3074 (Ar–H), 2942 (C–H str of CH3), 1741 (C=O, ester), 812 (Ar–H), 
610 (C–Cl), 787 (Ar–H). 1H-NMR (300 MHz, DMSO-d6, δ / ppm ): 8.31 (1H, s, 
NH of pyridine ring), 7.36–7.19 (5H, m, Ph-ring), 4.76 (1H, s, C4–H), 4.18 (4H, 
q, 3C–OCH2CH3 and C5–OCH2CH3), 2.21 (6H, s, C2–CH3 and C6–CH3), 1.34 
(6H, t, C2–OCH2CH3 and C6–OCH2CH3). 13C-NMR (300 MHz, DMSO-d6, δ / 
/ ppm): 131.4, 128.1, 130.8, 142.5 (Ph–Cl), 152.5 (C2,6), 34.6 (C4), 103.9 (3,5- 
-COOCH2CH3), 60.3 (3,5-COOCH2CH3), 15.2 (3,5-COOCH2CH3), 18.6 (2,6- 
-CH3). MS (m/z (relative abundance, %)): 364.90 (M++1, 21.2), 275.57, 219.70, 
185.26, 171.23, 157.21, 144.21 
Diethyl 4-(4-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbo-
xylate (1d). Yield: 56 %; m.p. 240 °C; Anal. Calcd. for C19H23NO5: C, 69.07; H, 
6.71; N, 4.06 %. Found: C, 9.03; H, 6.75; N, 4.01 %. IR (KBr, cm–1): 3342 (N–H 
str), 3024 (Ar–H), 2922 (C–H str of CH3), 1764 (C=O, ester), 1447 (C–OH), 814 
(Ar–H). 1H-NMR (300 MHz, DMSO-d6, δ / ppm): 9.47 (1H, s, C–OH), 8.41 
(1H, s, NH of pyridine ring), 6.34–7.07 (4H, m, Ph-ring), 4.67 (1H, s, C4–H), 4.28 
(4H, q, C3–OCH2CH3 and C5–OCH2CH3), 2.12 (6H, s, C2–CH3 and C6–CH3), 
1.28 (6H, t, C2–OCH2CH3 and C6–OCH2CH3). 13C-NMR (300 MHz, DMSO- 
-d6, δ / ppm ): 155.6, 116.2, 131.2, 138.2 (Ph-OH), 151.4 (C2,6), 44.9 (C4), 
101.4 (3,5-COOCH2CH3), 62.3 (3,5-COOCH2CH3), 14.1(3,5-COOCH2CH3), 
18.4 (2,6-CH3). MS (m/z (relative abundance, %)): 346.81 (M++1, 12.3), 310.45, 
257.81, 201.48, 187.22, 173.28, 157.21. 
Diethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarbo-
xylate (1e). Yield: 69 %; m.p.197 °C; Anal. Calcd. for C19H22N2O6: C, 60.95; H, 
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7.48; N, 7.48 %. Found: C, 60.91; H, 7.42; N, 7.41 %. IR (KBr, cm–1): 3354 (N–H 
str), 3037 (Ar–H), 2973 (C–H str of CH3), 1762 (C=O, ester), 1536 (C–NO2), 
812 (Ar–H). 1H-NMR (300 MHz, DMSO-d6, δ / ppm): 8.13–7.47 (4H, m, Ph- 
-ring), 8.11 (1H, s, NH of pyridine ring), 4.79 (1H, s, C4–H), 4.25 (4H, q, C3– 
–OCH2CH3 and C5–OCH2CH3), 2.31 (6H, s, C2–CH3 and C6–CH3), 1.37 (6H, 
t,  C2–OCH2CH3 and C6–OCH2CH3); 13C-NMR (300 MHz, DMSO-d6,  δ  / 
/ ppm): 144.8, 123.6, 126.9, 151.0 (Ph–NO2), 152.2 (C2,6), 43.9 (C4), 103.2 
(3,5-COOCH2CH3), 60.8 (3,5-COOCH2CH3), 14.4 (3,5-COOCH2CH3), 18.8 
(2,6-CH3). MS (m/z  (relative abundance, %)): 375.22 (M++1, 21.2), 286.26, 
185.26, 171.23, 157.21. 
Diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbo-
xylate (1f). Yield: 72 %; m.p. 197 °C; Anal. Calcd. for C20H25NO5: C, 66.83; H, 
7.01; N, 3.90 %. Found: C, 66.87; H, 7.07; N, 3.97 %. IR (KBr, cm–1); 3352 (N–H 
str), 3026 (Ar–H), 2961 (C–H str of CH3 ), 1742 (C=O, ester), 823 (Ar–H). 1H- 
-NMR (300 MHz, DMSO-d6, δ / ppm): 8.21 (1H, s, NH of pyridine ring), 6.86– 
–7.17 (5H, m, Ph-ring), 4.69 (1H, s, C4–H), 4.23 (4H, q, C3–OCH2CH3 and C5– 
–OCH2CH3), 3.84 (3H, s, –OCH3), 2.23 (6H, s, C2–CH3 and C6–CH3), 1.30 
(6H, t, C2–OCH2CH3 and C6–OCH2CH3). 13C-NMR (300 MHz, DMSO-d6, δ / 
/ ppm): 157.2, 114.6, 129.3, 135.9 (Ph), 158.3 (C2,6), 102.3 (3,5-COOCH2CH3), 
61.5 (3,5-COOCH2CH3), 55.7 (Ph–OCH3), 43.6 (C4), 14.8 (3,5-COOCH2CH3), 
18.0 (2,6-CH3). MS (m/z (relative abundance, %)): 360.44 (M++1, 41.2), 331.81, 
287.31, 243.25, 187.23, 157.21. 
Diethyl 4-(4-(dimethylamino)phenyl)-2,6–dimethyl-1,4-dihydropyridine-3,5- 
-dicarboxylate (1g). Yield: 56 %; m.p. 227 °C; Anal. Calcd. for C21H28N2O4: C, 
67.72; H,7.58; N, 7.52 %. Found: C, 67.77; H, 7.52; N, 7.58 %. IR (KBr, cm–1): 
3348 (N–H str), 3027 (Ar–H), 2956 (C–H str of CH3), 1761 (C=O, ester), 808 
(Ar–H). 1H-NMR (300 MHz, DMSO-d6, δ / ppm ): 8.37 (1H, s, NH of pyridine 
ring), 7.28–7.21 (5H, m,  Ph-ring), 4.70 (2H, s,  C4–H), 4.22 (4H, q, C3– 
–OCH2CH3 and C5–OCH2CH3), 3.12 (6H, s, –N(CH3)2), 2.28 (6H, s, C2–CH3 
and C6–CH3), 1.32 (6H, t, C2–OCH2CH3 and C6–OCH2CH3). 13C-NMR (300 
MHz, DMSO-d6, δ / ppm): 128.3, 112.9, 148.5, 133.9 (Ph), 151.8 (C2,6), 43.8 
(C4), 102.8 (3,5-COOCH2CH3), 60.5 (3,5-COOCH2CH3), 40.8 (–N(CH3)2), 
13.9 (3,5-COOCH2CH3), 18.9 (2,6-CH3). MS (m/z  (relative abundance, %)): 
373.44 (M++1, 51.8), 284.35, 228.33, 185.26, 171.23, 157.21. 
4-(Furan-2-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid, 3,5- 
-bis[2-(aminothioxomethyl)hydrazide]  (2a). Yield: 63 %; m.p. 161 °C;  Anal. 
Calcd. for C15H19N7O3S2: C, 44.00; H, 4.68; N, 23.94 ; S, 15.66 %. Found: C, 
44.06; H, 4.62; N, 23.97; S, 15.62 %. IR (KBr, cm–1): 3372 (N–H), 3200 (NH– 
–C=O), 3218 (NH2), 3021 (Ar–H), 1260 (C=S), 1091 (N–C–N), 828 (Ar–H). 1H- 
-NMR (300 MHz, CDCl3, δ / ppm): 9.62 (2H, s, NH2), 8.43 (1H, s, NH of pyri-
dine ring), 8.09 (1H, d, C3–CONH and C5–CONH), 7.51 (1H, d, 5’-H-furyl), 
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6.24 (1H, d, 4’-H-furyl), 6.24 (1H, d, 3’-H-furyl); 5.17 (2H, s, C4–H), 2.28 (6H, 
s, C2–CH3 and C6–CH3), 2.02 (1H, d, NHCS). 13C-NMR (300 MHz, CDCl3, δ / 
/ ppm): 111.8, 108.3, 143.2, 152.8 (C4 in furyl ring), 105.3 (C3,5 in pyridine ring), 
166.2 (C=O), 182.1 (C=S), 148.9 (C2,6 in pyridine ring), 35.3 (C4 in pyridine 
ring), 18.2 (C2,6–CH3 in pyridine ring); MS (m/z, (relative abundance, %)): 410 
(M++1, 30.2), 291.30, 161.27, 175.22, 147.12, 81.11. 
2,6-Dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid, 3,5-bis[2- 
-(aminothioxomethyl)hydrazide] (2b). Yield: 53 %; m.p. 192 °C; Anal. Calcd. 
for C17H21N7O2S2: C, 48.67; H, 5.50; N, 23.37; S, 15.29 %. Found: C, 48.64; H, 
5.57; N, 23.31; S, 15.34 %. IR (KBr, cm–1): 3370 (N–H), 3175 (NH–C=O), 3218 
(NH2), 3034 (Ar–H), 1718 (C=O), 1260 (C=S), 1091 (N–C–N), 808 (Ar–H). 1H- 
-NMR (300 MHz, CDCl3, δ / ppm): 9.60 (2H, s, NH2), 8.40 (1H, s, NH of pyri-
dine ring ), 8.11 (1H, d, C3–CONH and C5–CONH), 7.39–7.22 (5H, m, Ph- 
-ring), 5.20 (2H, s, C4–H), 2.37 (6H, s, C2–CH3 and C6–CH3), 2.12 (1H, d, 
–NHCS); 13C-NMR (300 MHz, CDCl3, δ / ppm): 131.3, 128.5, 130.9, 141.8 (C4 
in furyl ring), 106.8 (C3,5 in pyridine ring), 164.6 (C=O), 182.8 (C=S), 147.9 
(C2,6 in pyridine ring), 34.6 (C4 in pyridine ring), 18.9 (2,6-CH3 in pyridine 
ring); MS (m/z,(relative abundance, %)): 420.20 (M++1, 20.1), 301.34, 241.28, 
185.2, 157.21, 81.11. 
4-(4-Chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid, 
3,5-bis[2-(aminothioxomethyl)hydrazide] (2c). Yield: 68 %; m.p. 194 °C; Anal. 
Calcd. for C17H20ClN7O2S2: C, 4.98; H, 4.40; N, 21.60; S, 14.14 %. Found: C, 
44.92; H, 4.46; N, 21.64; S, 14.18 %. IR (KBr, cm–1): 3325 (N–H), 3231 (NH2), 
3198 (NH–C=O), 3024 (Ar–H), 1265 (C=S), 1707(C=O), 1097 (N–C–N), 810 
(Ar–H), 623 (C–Cl). 1H-NMR (300 MHz, CDCl3, δ / ppm): 9.41 (2H, s, NH2), 
8.41 (1H, s, NH of pyridine ring), 8.11 (1H, d, C3–CONH and C5–CONH ), 
7.38–7.14 (5H, m, Ph-ring), 5.10 (2H, s, C4–H), 2.45 (6H, s, C2–CH3 and C6–
CH3), 2.08 (1H, d, –NHCS). 13C-NMR (300 MHz, CDCl3,  δ / ppm): 128.7, 
108.3, 143.2, 152.8 (C4 in furyl ring), 105.3 (C3,5 in pyridine ring ), 166.2 
(C=O), 182.1 (C=S), 148.9 (C2,6 in pyridine ring), 39.3 (C4 in pyridine ring), 
18.2 (2,6–CH3 in pyridine ring); MS (m/z  (relative abundance, %)): 454.12 
(M++1, 12.3), 335.78, 275.73, 219.70, 157.21, 81.11. 
4-(4-Hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid, 
3,5-bis[2-(aminothioxomethyl)hydrazide] (2d). Yield: 74 %; m.p. 201 °C; Anal. 
Calcd. for C17H21N7O3S2: C, 46.88; H, 22.51; N, 4.86; S, 14.72 %. Found: C, 
46.81; H, 22.57; N, 4.81; S, 14.77 %. IR (KBr, cm–1): 3342 (N–H), 3220 (NH2), 
3192 (NH–C=O), 3028 (Ar–H), 1472 (C–OH), 1717 (C=O), 1242 (C=S), 1091 (N– 
–C–N). 1H-NMR (CDCl3, δ / ppm ): 9.71 (2H, s, NH2), 9.41 (1H, s, OH), 8.64 
(1H, s, NH of pyridine ring ), 8.01 (1H, d, C3–CONH and C5–CONH ), 7.33– 
–7.27 (5H, m, Ph-ring), 5.11 (2H, s, C4–H), 2.25 (6H, s, C2–CH3 and C6–CH3), 
2.02 (1H, d, –NHCS). 13C-NMR (300 MHz, CDCl3, δ / ppm): 155.8, 137.1, 
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130.3, 114.2 (C4 in 4-OH-phenyl ring), 102.9 (3,5-C in pyridine ring), 164.9 
(C=O), 184.6 (3,5 C=S), 148.1(C2,6 in pyridine ring), 43.8 (C4 in pyridine ring), 
19.2 (2,6–CH3 in pyridine ring). MS (m/z (relative abundance, %)): 435.52 
(M++1, 27.2), 257.28, 201.26, 173.21, 157.21, 81.11.  
2,6-Dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid, 
3,5-bis[2-(aminothioxomethyl)hydrazide] (2e). Yield: 76 %; m.p. 190 °C; Anal. 
Calcd. for C17H20N8O4S2: C, 43.96; H, 4.34; N, 24.12; S, 15.81 %. Found: C, 
43.91; H, 4.38; N, 24.17; S, 15.87 %. IR (KBr, cm–1): 3310 (N–H), 3241 (NH2), 
3218 (NH–C=O), 3041 (Ar–H), 1710 (C=O), 1530 (C–NO2), 1272 (C=S), 1094 
(N–C–N). 1H-NMR (300 MHz, CDCl3, δ / ppm): 9.77 (2H, s, NH2), 8.60 (1H, s, 
NH of pyridine ring ), 8.15 (1H, d, C3–CONH and C5–CONH ), 7.42–7.18 (5H, 
m, Ph-ring), 5.17 (2H, s, C4–H), 2.31 (6H, s, C2–CH3 and C6–CH3), 2.08 (1H, d, 
–NHCS). 13C-NMR (300 MHz, CDCl3, δ / ppm): 143.2, 123.7, 126.7 (C4 in 4- 
-NO2-phenyl ring), 102.9 (3,5-C in pyridine ring ), 164.9 (C=O), 181.9 (C=S), 
149.9 (2,6-C in pyridine ring), 44.5 (4-C in pyridine ring), 19.7(2,6-C–CH3 in 
pyridine ring). MS (m/z (relative abundance, %)): 465.52 (M++1, 12.78), 346.34, 
286.20, 258.23, 230.21, 202.20, 81.11. 
4-(4-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid, 
3,5-bis[2-(aminothioxomethyl)hydrazide] (2f). Yield: 66 %; m.p. 210 °C; Anal. 
Calcd. for C18H23N7O3S2: C, 48.09; H, 5.16; N, 21.81; S, 14.27 %. Found: C, 
48.05; H, 5.19; N, 21.88; S,14.21 %. IR (KBr, cm–1): 3323 (N–H), 3251 (NH–
C=O), 3231 (NH2), 3034 (Ar–H), 1717 (C=O), 1251 (C=S), 1091 (N-C-N), 808 
(Ar–H). 1H-NMR (300 MHz, DMSO-d6, δ / ppm): 9.82 (2H, s, NH2), 8.57 (1H, 
s, N–H of pyridine ring), 8.05 (1H, d, C3–CONH and C5–CONH), 7.33–7.27 
(5H, m, Ph-ring), 5.21 (2H, s, C4–H), 3.81 (3H, s, –OCH3), 2.25 (6H, s, C2–CH3 
and C6–CH3), 2.10 (1H, d, –NHCS). 13C-NMR (300 MHz, CDCl3, δ / ppm): 
111.8, 108.3, 143.2, 152.8 (C4 in 4-CH3O-phenyl ring), 105.3 (3,5-C in pyridine 
ring ), 166.2 (3,5-C=O), 181.7 (3,5-C=S), 147.7 (2,6-C in pyridine ring), 44.7 
(C4 in pyridine ring), 18.8 (2,6-CH3 in pyridine ring), 55.9 (–OCH3); MS (m/z, 
(relative abundance, %)): 450.21 (M++1, 29.12), 331.36, 271.31, 243.25, 215.29, 
185.26, 157.21. 
4-[4-(Dimethylaminophenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbo-
xylic acid, 3,5-bis[2-(aminothioxomethyl)hydrazide] (2g). Yield: 61 %; m.p. 205 
°C; Anal. Calcd. for C19H26N8O2S2: C, 49.33; H, 5.67; N, 24.22; S, 13.86 %. 
Found: C, 49.37; H, 5.69; N, 24.27; S, 13.82 %. IR (KBr, cm–1): 3320 (N–H), 
3211 (NH2), 3118 (NH–C=O), 3021 (Ar–H), 1712 (C=O), 1248 (C=S), 1091 (N– 
–C–N), 812 (Ar–H). 1H-NMR (300 MHz, DMSO-d6,  δ  / ppm): 9.66 (2H, s, 
NH2), 8.52 (1H, s, NH of pyridine ring), 8.03 (1H, d, C3–CONH and C5– 
–CONH), 6.62–7.07 (4H, m, Ph-ring), 5.13 (2H, s, C4–H), 3.06 (1H, s, –N(CH3)2), 
2.19 (6H, s, C2–CH3 and C6–CH3), 2.07 (1H, d, NHCS). 13C-NMR (300 MHz, 
CDCl3, δ / ppm) 112.8, 134.8, 128.3, 148.2, 152.8 (C4 in 4-(CH3)2N-phenyl ring), 
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106.3 (3,5-C in pyridine ring ), 165.2 (C=O), 181.1 (C=S), 147.9 (2,6-C in pyri-
dine ring), 39.3 (C4 in pyridine ring), 40.8 (N(CH3)2), 46.5 (C4 in pyridine ring), 
18.2 (2,6-CH3 in pyridine ring). MS (m/z (relative abundance, %)): 463.22 
(M++1, 16.24), 432.56, 344.41, 284.35, 256.29, 213.23, 199.24, 185.26. 
Spectroscopy 
The IR spectra of compounds 1a–g showed an absorption band at 3332 to 
3354 cm–1 due to N–H stretching, another absorption band at 1741–1764 cm–1 
due to the keto group in the ester groups. Compound 1c showed an absorption 
band at 610 cm–1 corresponding the to Cl–C bonds, compound 1d showed an ab-
sorption band at 1447 cm–1 corresponding to the HO–C bonds and compound 1e 
showed an absorption band at 1536 cm–1 corresponding the O2N–C groups. The 
1H-NMR spectra of compounds 1a–g showed a singlet at δ 8.11–8.41 ppm, at-
tributable to the NH protons present in the 1,4-dihydropyridine ring, and another 
important singlet at δ 4.67–4.79 ppm, which was attributable to the C4–H proton 
present in the 1,4-dihydropyridine ring. The 13C-NMR spectra of compounds 1a–g 
showed peaks at δ 33.2–44.9 ppm, corresponding to C4 in the pyridine ring, δ 
101.4–103.9 ppm, corresponding to the 3,5-position of C–COOEt, and δ 150.7– 
–152.8 ppm, corresponding to the 2,6-position of C–CH3 in the pyridine ring. 
The mass spectral analysis of compounds 1a–g showed molecular ion peaks, 
which confirmed the molecular mass of these compounds. The IR spectra of 
compounds 2a–g showed an absorption band obtained at 3320–3372 cm–1 cor-
responding to the NH group present in the 1,4-dihydropyridine ring and another 
absorption band at 3118–3200 cm–1 which was due to NH–C=O stretching. An 
absorption band for the C=S group was observed at 1242–1272 cm–1. The 1H- 
-NMR spectra of 2a–g showed as a singlet a band at δ 8.41–8.64 ppm, attribu-
table to the NH protons present in the 1,4-dihydropyridine ring. The C4–H, CONH, 
NHCS and NH2 protons resonated as singlets at δ 5.10–5.21, 8.01–8.15, 2.02– 
–2.12 and 9.14–9.82 ppm, respectively. The 13C-NMR spectra of compounds 2a–g 
showed peaks at δ 163.1–166.2, 181.1–184.6, 34.6–46.5 and 18.2–19.7 ppm, 
corresponding to the 3,5-position of CO-NH group in the pyridine ring, the 3,5- 
-position of CS in the pyridine ring, the 4-position of carbon in the pyridine ring 
and the 2,6-position of CH3 in the pyridine ring, respectively. Mass spectral ana-
lysis of compounds 2a–g showed molecular ion peaks, which confirmed the 
molecular masses of these compounds. 
Antibacterial screening 
The bacterial zones of inhibition values (mm) are given in Table I. The anti-
microbial activities of compounds 1a–g and 2a–g were screened. The structure 
activity relationship (SAR) analysis of the base compounds 1a–g was compared 
with that of the thiosemicarbazone-containing compounds 2a–g. Ciprofloxacin 
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was used as a standard at 100 µg ml–1. Compounds 1a–g showed low activity 
compared with compounds 2a–g towards all the tested organisms. 
TABLE I. Antibacterial activity of the synthesized compounds 1a–g and 2a–g (disk diameter: 
7 cm) 
Compound  S. aureus  K. pneumoniae  E. coli  P. aeruginosa 
1a   – –  10  14 
1b  6 7 5 6 
1c  10 –  8 10 
1d  – 8 – – 
1e  5 5 6  12 
1f  – 6 5  15 
1g  5 –  10  6 
2a  9 –  16  30 
2b  17 18 12 18 
2c  25 15 13 10 
2d  15 16 25  – 
2e  13 12 16 20 
2f  11 18 15 22 
2g  10 7 18  16 
Ciprofloxacin 22 19 27 32 
Compounds 2a–g were screened for Staphylococcus aureus and compound 
2c was found to be highly active compared with the standard ciprofloxacin be-
cause it contained an amide group in the 3,5-position with C=S and a 4-chloro-
phenyl group in the fourth position. On the other hand, compounds 2a, 2b and 
2d–g had low activities compared with the standard ciprofloxacin.  
Compounds 2a–g were screened for Klebsiella pneumoniae, whereby com-
pounds 2b and 2f showed equipotent activity with the standard ciprofloxacin. On 
the other hand, compounds 2a, 2d–e and 2g had low activities compared with the 
standard ciprofloxacin.  
Compounds 2a–g were screened for Escherichia coli and the compound 2d 
was found to have an equipotent activity compared with the standard ciproflo-
xacin. On the other hand, compounds 2a–c and 2e–g had low activities compared 
with the standard ciprofloxacin.  
Compounds 2a–g were screened for Pseudomonas aeruginosa, whereby the 
compound 2a exhibited equipotent activity compared with the standard cipro-
floxacin, while the other compounds 2b–g had low activities compared with the 
standard ciprofloxacin. 
Antifungal screening 
The fungacidal zones of inhibition, mm, values are given in Table II. Com-
pounds 2a–g were screened for Aspergillus niger; the compounds 2b–g were less 
active compared with the standard clotrimazole, while compound 2a had no ac-
tivity. 
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Compounds 2a–g were screened for Candida albicans. Compound 2d was 
highly active compared with the standard clotrimazole because it contained an 
amide group in the 3,5-position with C=S and 4-hydroxyphenyl in the fourth po-
sition, while the other compounds 2a–c and 2e–g had lower activities than the 
standard clotrimazole. 
TABLE II. Antifungal activity of the synthesized compounds 1a–g and 2a–g (disk diameter: 
7 cm) 
Compound  A. niger  C. albicans  M. audouinii  C. neoformans 
1a  –  8 10 – 
1b  9 10 8  9 
1c  10 16  –  8 
1d  14 – 12 – 
1e  8 – – – 
1f  12 15 11  9 
1g  5 16  12 – 
2a  – 8 6 7 
2b  10 –  –  6 
2c  15 20 14 13 
2d  16 26 18 15 
2e  8 11  15  15 
2f  16 10 18 24 
2g  14 17 16  – 
Clotrimazole  22 24 26 25 
Compounds  2a–g were screened for Microsporum audouinii. The com-
pounds 2a and 2c–g had lower activity than the standard clotrimazole, while 
compound 2b was inactive. 
Compounds  2a–g were screened for Cryptococcus neoformans, the com-
pound 2f had equipotent activity with the standard clotrimazole, while the other 
compounds 2a–d and 2e had lower activities compared with the standard clotri-
mazole and compound 2g exhibited no activity. 
EXPERIMENTAL 
Chemistry 
The melting points were recorded in open capillary tubes and are reported uncorrected. 
The IR spectra were recorded in KBr on a Shimadzu 8201pc FTIR specrometer (4000–400 
cm-1). The 1H-NMR and 13C-NMR spectra were recorded on a Bruker DRX-300 MHz instru-
ment. The mass spectra (EI) were obtained on a Jeol JMS D-300 spectrometer operating at 70 
eV. Elemental analyses (C, H, N and S) were realized using an Element Analyzer, model Va-
rio EL III. The purity of the compounds was checked by thin layer chromatography (TLC). 
Synthesis of diethyl 4-(furan-2-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (1a) 
The reaction mixture consisting of ethyl acetoacetate (0.2 mol), furfural (0.1 mol) and 
ammonium hydroxide (0.1 mol) in methanol (20 mL) was heated at reflux for 4 h. The ob-
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tained solid was filtered off, washed with water and recrystallized using absolute ethanol. The 
above procedure was followed for the synthesis of compounds 1b–g.  
Synthesis of 4-(furan-2-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid, 
3,5-bis[2-(aminothioxomethyl)hydrazide] (2a) 
The reaction mixture consisting of compound 1a (0.1 mol), thiosemicarbazide (0.2 mol) 
dissolved in ethanol (30 mL) and a few drops DMSO was heated under reflux for 10 h. The 
obtained solid was allowed to cool and then poured into crushed ice. The solid was collected 
by filtration, washed with water and recrystallised using ethanol. The above procedure was 
followed for the synthesis of compounds 2b–g. 
In vitro antibacterial screening 
The compounds 1a–g and 2a–g were evaluated for their in vitro antibacterial activity 
against S. aureus (ATCC-25923), K. pneumoniae (recultured), E. coli (ATCC-25922) and P. 
aeruginosa (ATCC-27853) by the agar diffusion method22,23 using Mueller–Hinton agar (Hi- 
-Media) medium. Each compound was tested at a concentration of 100 μg mL-1 in DMSO. Ci-
profloxacin was used as the standard. The zone of inhibition (mm) was measured after 24 h 
incubation at 37 ºC.  
In vitro antifungal screening 
The compounds 1a–g and 2a–g were evaluated for their in vitro antifungal activity against 
A. niger, C. albicans, M. audouinii and C. neoformans (recultured) using an agar diffusion 
method24,25 with Sabouraud’s dextrose agar (Hi-Media). Each compound was tested at a con-
centration of 100 μg mL-1 in DMSO. Clotrimazole was used as the standard. The zone of in-
hibition (mm) was measured after 24 h incubation at 37 °C. 
CONCLUSIONS 
A new series of 1,4-dihydropyriodine derivatives (2a–g) was synthesized. 
The synthesized compounds were screened for their antibacterial activity, where-
by compound 2c was more active than ciprofloxacin against S. aureus organism. 
When the synthesized compounds were screened for their antifungal activity, a 
compound  2d showed higher activity than clotrimazole against C. albicans. 
These findings could be of importance for further studies in this field. 
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ИЗВОД 
СИНТЕЗА И АНТИМИКРОБНА АКТИВНОСТ НОВЕ СЕРИЈЕ ДЕРИВАТА 
1,4-ДИХИДРОПИРИДИНА 
R. SURENDRA KUMAR
1, A. IDHAYADHULLA
1, A. JAMAL ABDUL NASSER
1 и J. SELVIN
2 
1P. G. & Research Department of Chemistry, Jamal Mohamed College, Tiruchirappalli-620 020, Tamil Nadu и 
2Department of Microbiology, Bharathidasan University.Tiruchirappalli–620024, Tamil Nadu, India 
Ханчовом синтезом добијена је нова серија деривата 1,4-дихидропиридина (1a–g). Једи-
њења 1а–g реаgовала су са тиосемикарбазидима и добијена је нова серија једињења 2а–g. 
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Структура синтетисаних једињења је потврђена ИЦ, 1H-NMR, 13C-NMR и масеним спектрима 
и елементалном анализом. Синтетисаним једињењима је одређена антибикробна активност. 
(Примљено 27. новембра 2009, ревидирано 21. јула 2010) 
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